Abderrazzak Merzouki serves as Executive at Sunshine Biopharma, Inc, where they oversee executive responsibilities. Since joining the company, Abderrazzak Merzouki has executed 14 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 6, 2021 involved receiving (via award) 20,000,000 shares valued at $0.
Abderrazzak Merzouki currently holds 23,342,500 shares of Sunshine Biopharma, Inc (SBFM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Abderrazzak Merzouki has been a net neutral trader of SBFM stock. They have purchased $0 and sold $0 worth of shares.
Abderrazzak Merzouki's most recent insider trade was on Jan 6, 2021, when they sold 20,000,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 20, 2019 | SBFM | $0 | Award | 1,100,000 | $N/A | Discretionary |
| Sep 2, 2019 | SBFM | $0 | Award | 13,000,000 | $N/A | Discretionary |
| Aug 27, 2018 | SBFM | $0 | Award | 38,000,000 | $N/A | Discretionary |
| Aug 27, 2018 | SBFM | $0 | Award | 38,000,000 | $N/A | Discretionary |
| Jun 20, 2018 | SBFM | $0 | Award | 27,000,000 | $N/A | Discretionary |
| Jun 20, 2018 | SBFM | $0 | Award | 27,000,000 | $N/A | Discretionary |
| Apr 22, 2018 | SBFM | $0 | Award | 12,000,000 | $N/A | Discretionary |
| Jul 20, 2017 | SBFM | $0 | Award | 14,000,000 | $N/A | Discretionary |
| Jul 20, 2017 | SFBM | $0 | Award | 14,000,000 | $N/A | Discretionary |
| Dec 6, 2016 | SBFM | $0 | Award | 28,000,000 | $N/A | Discretionary |
| Dec 6, 2016 | SBFM | $0 | Award | 26,000,000 | $N/A | Discretionary |
| Apr 22, 2016 | SBFM | $0 | Award | 12,000,000 | $N/A | Discretionary |